Jane Street Group, LLC Ultragenyx Pharmaceutical Inc. Put Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$40.21 - $59.36 $4.74 Million - $7 Million	117,900 New	117,900 $6.55 Million
Q1 2022 May 17, 2022	SELL	$62.2 - $84.4 $1.79 Million - $2.43 Million	-28,800 Reduced 60.0%	19,200 $1.39 Million
Q4 2021 Feb 15, 2022	BUY	$73.71 - $87.86 $316,953 - $377,798	4,300 Added 9.84%	48,000 $4.04 Million
Q3 2021 Nov 16, 2021	BUY	$77.92 - $102.4 $1.93 Million - $2.54 Million	24,800 Added 131.22%	43,700 $3.94 Million
Q2 2021 Aug 16, 2021	BUY	$92.19 - $115.71 $1.26 Million - $1.59 Million	13,700 Added 263.46%	18,900 $1.8 Million
Q2 2020 Aug 17, 2020	BUY	$46.91 - $78.22 $243,931 - $406,744	5,200 New	5,200 $407,000

325

85.7M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.13B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.